在患有恶性瘤的孕妇患者中,在分娩时选择避孕和绝育
Chelsey A Harris1, Rachel S Mandelbaum2, Alesandra R Rau1,3
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California, USA.
Acta obstetricia et gynecologica Scandinavica
|August 14, 2023
概括
患有癌症的孕妇在分娩时根据她们的特定癌症类型选择不同的避孕或绝育方法. 这项全国性的研究强调了癌症患者对长效可逆避孕和手术绝育的不同偏好.
科学领域:
- 生殖健康 生殖健康
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 怀孕期间的恶性癌症很少见,导致对避孕和分娩时绝育选择的数据有限.
- 了解这些选择对于明智的患者护理和生殖规划至关重要.
研究的目的:
- 调查孕妇在分娩时选择的长效可逆避孕 (LARC) 和手术绝育程序的类型.
- 将这些选择与没有恶性瘤的孕妇患者进行比较.
主要方法:
- 一项使用美国国家住院患者样本 (NIS) (2017-2020) 的横截面研究.
- 在患有特定癌症 (乳腺癌,白血病,淋巴瘤,甲状腺癌,宫癌,黑色素瘤) 的孕妇和对照组中比较避孕和绝育选择.
- 使用了多项回归分析,控制了临床和分娩特征.
主要成果:
- 患有乳腺癌的患者更有可能选择双边沙切除术或子宫内装置 (IUD).
- 白血病患者更喜欢皮下植入物,而淋巴瘤和宫癌患者的双边切除术率增加.
- 甲状腺癌患者更喜欢双边输卵管绑定,而没有宫癌或黑色素瘤癌患者选择LARC.
- 年轻患者 (<30岁) 患有某些癌症 (乳腺癌,宫癌,淋巴瘤,黑色素瘤) 的几率增加了特定的绝育程序.
结论:
- 在不同类型恶性瘤的孕妇患者中,分娩时的避孕和绝育偏好显著不同.
- 这些发现强调了需要个性化咨询和照顾,根据特定的癌症诊断和患者特征量身定制.
相关概念视频
Birth Control Methods
337
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
337
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Preventive Healthcare Services
1.1K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.1K
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
243
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
243


